Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
via Wikipedia infobox
via PubMed
{{Infobox drug | verifiedrevid = | image = Osimertinib.svg | image_class = skin-invert-image | width = 250 | alt = | USAN = osimertinib mesylate | JAN = osimertinib mesilate
| tradename = Tagrisso, others | Drugs.com = | MedlinePlus = a616005 | DailyMedID = Osimertinib | pregnancy_AU = D | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = EB04
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).